Long-term opiate effects on amphetamine-induced dopamine release in the nucleus accumbens core and conditioned place preference

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 2, 2004, Pages 327-335

  He, Shaunteng ^a   Li, Ning ^a   Grasing, Kenneth ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

Amphetamine; Conditioned place preference; Dependence; Dopamine; Morphine; Nucleus accumbens; Opiate; Psychostimulant; Withdrawal syndrome

Indexed keywords

AMPHETAMINE; DOPAMINE; MORPHINE; OPIATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTINUOUS INFUSION; CONTROLLED STUDY; DIALYSATE LEVEL; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG DEPENDENCE; DRUG WITHDRAWAL; LOCOMOTION; LONG TERM EXPOSURE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; SUBSTANCE ABUSE;

ANIMALIA; RATTUS NORVEGICUS;

EID: 1642575177     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.11.014     Document Type: Article

References (50)

1. Acquas E., Di Chiara G. Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J. Neurochem. 58:1992;1620-1625.
2. Acquas E., Carboni E., DiChiara G. Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur. J. Pharmacol. 193:1991;133-134.
3. Bardo M.T. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit. Rev. Neurobiol. 12:1998;37-67.
4. Bell S.M., Stewart R.B., Thompson S.C., Meisch R.A. Food-deprivation increases cocaine-induced conditioned place preference and locomotor activity in rats. Psychopharmacology. 131:1997;1-8.
5. Bonci A., Bernardi G., Grillner P., Mercuri N.B. The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction? Trends Pharmacol. Sci. 24:2003;172-177.
6. Cadoni C., Di Chiara G. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience. 90:1999;447-455.
7. Crippens D., Robinson T.E. Withdrawal from morphine or amphetamine: different effects on dopamine in the ventral-medial striatum studied with microdialysis. Brain Res. 650:1994;56-62.
8. Cryan J.F., Hoyer D., Markou A. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol. Psychiatry. 54:2003;49-58.
9. Dackis C.A., Gold M.S. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci. Biobehav. Rev. 9:1985;469-477.
10. Di Chiara G. Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav. Brain Res. 137:2002;75-114.
11. Diana M., Pistis M., Muntoni A., Gessa G. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J. Pharmacol. Exp. Ther. 272:1995;781-785.
12. Diana M., Muntoni A.L., Pistis M., Melis M., Gessa G.L. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur. J. Neurosci. 11:1999;1037-1041.
13. Ghosh S., Grasing K. Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal. Neurochem. Res. 24:1999;95-107.
14. Ghosh S., Patel A.H., Cousins M., Grasing K. Different effects of opiate withdrawal on dopamine turnover, uptake, and release in the striatum and nucleus accumbens. Neurochem. Res. 23:1998;875-885.
15. Grasing K., Ghosh S. Selegiline prevents long-term changes in dopamine efflux and stress immobility during the second and third weeks of abstinence following opiate withdrawal. Neuropharmacology. 37:1998;1007-1017.
16. Grasing K., Li N., He S., Parrish C., Delich J., Glowa J. A new progressive ratio schedule for support of morphine self-administration in opiate dependent rats. Psychopharmacology. 168:2003;387-396.
17. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12:1992;483-488.
18. Kalivas P.W., Duffy P. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons. J. Pharmacol. Exp. Ther. 241:1987;204-212.
19. King G.R., Kuhn C., Ellinwood E.H.J. Dopamine efflux during withdrawal from continuous or intermittent cocaine. Psychopharmacology. 111:1993;179-184.
20. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology. 98:1989;357-362.
21. Markou A., Kosten T.R., Koob G.F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology. 18:1998;135-174.
22. McBride W.J., Murphy J.M., Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav. Brain Res. 101:1999;129-152.
23. McCann U.D., Lowe K.A., Ricaurte G.A. Long-lasting effects of recreational drugs of abuse on the central nervous system. Neuroscientist. 3:1997;399-411.
24. Nieto M.M., Wilson J., Cupo A., Roques B.P., Noble F. Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study. J. Neurosci. 22:2002;1034-1041.
25. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, New York.
26. Pifl C., Drobny H., Reither H., Hornykiewicz O., Singer E.A. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol. Pharmacol. 47:1995;368-373.
27. Pollock J., Kornetsky C. Reexpression of morphine-induced oral stereotypy six months after last morphine sensitizing dose. Pharmacol. Biochem. Behav. 53:1996;67-71.
28. Post R.M. Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life Sci. 26:1980;1275-1282.
29. Pothos E.N., Creese I., Hoebel B.G. Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J. Neurosci. 15:1995;6640-6650.
30. Povlock S.L., Schenk J.O. A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine. J. Neurochem. 69:1997;1093-1105.
31. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18:1993;247-291.
32. Rogawski M.A., Barker J.L. Effects of 4-aminopyridine on calcium action potentials and calcium current under voltage clamp in spinal neurons. Brain Res. 280:1983;180-185.
33. Salamone J.D., Correa M., Mingote S., Weber S.M. Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. J. Pharmacol. Exp. Ther. 305:2003;1-8.
34. Schenk S., Partridge B. Sensitization and tolerance in psychostimulant self-administration. Pharmacol. Biochem. Behav. 57:1997;543-550.
35. Schulteis G., Koob G.F. Reinforcement processes in opiate addiction: a homeostatic model. Neurochem. Res. 21:1996;1437-1454.
36. Shippenberg T.S., Heidbreder C. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J. Pharmacol. Exp. Ther. 273:1995;808-815.
37. Shippenberg T.S., Emmett-Oglesby M.W., Herz A. Morphine-induced place conditioning is not confounded by drug-induced alterations in locomotor activity. Pharmacol. Biochem. Behav. 32:1989;129-132.
38. Shippenberg T.S., Heidbreder C., Lefevour A. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur. J. Pharmacol. 299:1996;33-39.
39. Spanagel R., Almeida O.F., Shippenberg T.S. Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse. 14:1993;243-245.
40. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 4:1993;289-312.
41. Sulzer D., Chen T.K., Lau Y.Y., Kristensen H., Rayport S., Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15:1995;4102-4108.
42. Szumlinski K.K., Maisonneuve I.M., Glick S.D. The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment. Brain Res. 864:2000;13-23.
43. Tjon G.H., De Vries T.J., Ronken E., Hogenboom F., Wardeh G., Mulder A.H.et al. Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation. Eur. J. Pharmacol. 252:1994;205-212.
44. Tjon G.H.K., De Vries T.J., Ronken E., Hogenboom F., Wardeh G., Mulder A.H.et al. Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta and kappa opioid receptor regulation. Eur. J. Pharmacol. 252:1994;205-212.
45. Tjon G.H.K., De Vries T.J., Nestby P., Wardeh G., Mulder A.H., Schoffelmeer A.N.M. Intermittent and chronic morphine treatment induces long-lasting changes in delta-opioid receptor-regulated acetylcholine release in rat striatum and nucleus accumbens. Eur. J. Pharmacol. 283:1995;169-176.
46. Tjon Tien Ril H.K., DeVries T.J., Wardeh G., Hogenboom F., Mulder A.H., Schoffelmeer A.N. Long-lasting reciprocal changes in striatal dopamine and acetylcholine release upon morphine withdrawal. Eur. J. Pharmacol. 235:1993;321-322.
47. Van den Berg C.L., Kitchen I., Gerrits M.A., Spruijt B.M., Van Ree J.M. Morphine treatment during juvenile isolation increases social activity and opioid peptides release in the adult rat. Brain Res. 830:1999;16-23.
48. Vanderschuren L.J., Tjon G.H., Nestby P., Mulder A.H., Schoffelmeer A.N., De Vries T.J. Morphine-induced long-term sensitization to the locomotor effects of morphine and amphetamine depends on the temporal pattern of the pretreatment regimen. Psychopharmacology. 131:1997;115-122.
49. Volkow N.D., Fowler J.S., Wang G.J. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav. Pharmacol. 13:2002;355-366.
50. Wayment H., Meiergerd S.M., Schenk J.O. Relationships between the catechol substrate binding site and amphetamine, cocaine, and mazindol binding sites in a kinetic model of the striatal transporter of dopamine in vitro. J. Neurochem. 70:1998;1941-1949.